Rita Marchi

479 total citations
40 papers, 366 citations indexed

About

Rita Marchi is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Epidemiology. According to data from OpenAlex, Rita Marchi has authored 40 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 19 papers in Hematology and 3 papers in Epidemiology. Recurrent topics in Rita Marchi's work include Blood properties and coagulation (31 papers), Platelet Disorders and Treatments (14 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Rita Marchi is often cited by papers focused on Blood properties and coagulation (31 papers), Platelet Disorders and Treatments (14 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Rita Marchi collaborates with scholars based in Venezuela, United States and Switzerland. Rita Marchi's co-authors include John W. Weisel, Carmen Luisa Arocha-Piñango, Belsy Guerrero, John W. Weisel, Robert A.S. Ariëns, Marlien Pieters, Anetta Undas, M.P.M. De Maat, Chandrasekaran Nagaswami and Héctor Rojas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the New York Academy of Sciences and Clinica Chimica Acta.

In The Last Decade

Rita Marchi

39 papers receiving 363 citations

Peers

Rita Marchi

PRM

HEMAT

CCM

EPIDE

G. J. Stewart United States

Sophie Voisin France

Paulo Vilar Saavedra United States

Syed Muhammad Tahir Pakistan

Kristof Van Avondt Netherlands

Zhijian Wang China

Cynthia M. Pruss Canada

Yong Gon Cho South Korea

Ad Castel Netherlands

Marco Heestermans France

G. J. Stewart United States

Rita Marchi

79 ×0.4

PRM

83 ×0.6

HEMAT

53 ×1.3

CCM

28 ×0.8

EPIDE

85 ×2.4

Citations per year, relative to Rita Marchi Rita Marchi (= 1×) peers G. J. Stewart

Countries citing papers authored by Rita Marchi

Since Specialization

Citations

This map shows the geographic impact of Rita Marchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Marchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Marchi more than expected).

Fields of papers citing papers by Rita Marchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Marchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Marchi. The network helps show where Rita Marchi may publish in the future.

Co-authorship network of co-authors of Rita Marchi

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Marchi. A scholar is included among the top collaborators of Rita Marchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Marchi. Rita Marchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marchi, Rita, et al.. (2023). Physiological correction of hereditary mild hypofibrinogenemia during pregnancy. Haemophilia. 29(3). 836–843. 2 indexed citations

Calderara, Debora Bertaggia, Rita Marchi, Stéphane Durual, et al.. (2023). Pharmacodynamics Monitoring of Emicizumab in Patients with Hemophilia A. Thrombosis and Haemostasis. 123(10). 955–965. 4 indexed citations

Glauser, Frederick L., Stéphane Noble, Pierre Fontana, et al.. (2023). PB0045 SEM and 3D Reconstruction of ex-vivo Arterial Thrombi: A Pilot Study. Research and Practice in Thrombosis and Haemostasis. 7. 100717–100717.

Khayat, Claudia Djambas, Rita Marchi, Stéphane Durual, et al.. (2022). Impact of Fibrinogen Infusion on Thrombin Generation and Fibrin Clot Structure in Patients with Inherited Afibrinogenemia. Thrombosis and Haemostasis. 122(9). 1461–1468. 5 indexed citations

Marchi, Rita, Marguerite Neerman‐Arbez, Guillaume Mourey, et al.. (2021). Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls. Blood Coagulation & Fibrinolysis. 32(2). 108–114. 5 indexed citations

Pinto, Eleonora, Rita Marchi, Francesco Cavallin, et al.. (2020). QOLEC2: a randomized controlled trial on nutritional and respiratory counseling after esophagectomy for cancer. Supportive Care in Cancer. 29(2). 1025–1033. 3 indexed citations

Marchi, Rita, et al.. (2020). Fibrin clot properties to assess the bleeding phenotype in unrelated patients with hypodysfibrinogenemia due to novel fibrinogen mutations. Thrombosis Research. 197. 56–64. 7 indexed citations

Marchi, Rita, Héctor Rojas, Arlette Ruiz‐Sàez, et al.. (2017). A novel fibrinogen mutation: FGA g. 3057 C > T (p. Arg104 > Cys) impairs fibrinogen secretion. SHILAP Revista de lepidopterología. 17(1). 22–22. 2 indexed citations

Castillo, Oscar, et al.. (2016). Endothelial fibrinolytic response onto an evolving matrix of fibrin. PubMed. 16(1). 9–9. 3 indexed citations

10.

Marchi, Rita & Héctor Rojas. (2015). Effect of von Willebrand factor on clot structure and lysis. Blood Coagulation & Fibrinolysis. 26(5). 533–536. 8 indexed citations

11.

Marchi, Rita, et al.. (2014). Comparison by sex between thrombin generation and fibrin network characteristics in a healthy population. Clinica Chimica Acta. 441. 86–89. 14 indexed citations

12.

Marchi, Rita, et al.. (2012). A novel mutation in the FGB: c.1105C>T turns the codon for amino acid Bβ Q339 into a stop codon causing hypofibrinogenemia. Blood Cells Molecules and Diseases. 50(3). 177–181. 4 indexed citations

13.

Pieters, Marlien, Anetta Undas, Rita Marchi, et al.. (2012). An international study on the standardization of fibrin clot permeability measurement: methodological considerations and implications for healthy control values. Journal of Thrombosis and Haemostasis. 10(10). 2179–2181. 67 indexed citations

14.

Marchi, Rita, Bethany L. Walton, Colleen S. McGary, et al.. (2012). Dysregulated coagulation associated with hypofibrinogenaemia and plasma hypercoagulability: Implications for identifying coagulopathic mechanisms in humans. Thrombosis and Haemostasis. 108(9). 516–526. 10 indexed citations

15.

Rojas, Héctor, Michael Meyer, Oscar Castillo, et al.. (2011). A novel missense mutation in the FGB g. 3354 T>A (p. Y41N), Fibrinogen Caracas VIII. Thrombosis and Haemostasis. 105(4). 627–634. 6 indexed citations

16.

Marchi, Rita, Chandrasekaran Nagaswami, & John W. Weisel. (2009). Fibrin formation and lysis studies in dengue virus infection. Blood Coagulation & Fibrinolysis. 20(7). 575–582. 20 indexed citations

17.

Marchi, Rita, Michael Meyer, Jeannette Soria, et al.. (2006). Fibrinogen Guarenas, an abnormal fibrinogen with an Aα-chain truncation due to a nonsense mutation at Aα 467 Glu (GAA)→stop (TAA). Thrombosis Research. 118(5). 637–650. 15 indexed citations

18.

Marchi, Rita, Claudine Soria, Manouchehr Mirshahi, et al.. (2000). Thrombotic Dysfibrinogenemia. Thrombosis Research. 99(2). 187–193. 19 indexed citations

19.

Marchi, Rita, Ulf Lundberg, Norma B de Bosch, & Carmen Luisa Arocha-Piñango. (1998). Fibrinogen Caracas I: a dysfibrinogenemia with a hemorrhagic diathesis associated with diminished fibrin fiber diameter and reduced fibrin gel porosity.. PubMed. 9(8). 733–9. 2 indexed citations

20.

Lundberg, Ulf, et al.. (1995). Fibrinogen Guarenas I: Partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization. Thrombosis Research. 78(2). 95–106. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact